Search For "covaxin"
Updated : 17 hours, 33 min ago IST
New Delhi [India], May 15 (ANI): Pointing out the Centre's delay in taking decision, former finance minister and senior Congress leader P Chidambaram on Saturday asked who will be accountable for the avoidable infections and loss of lives due to the central government's delay to invite other
Updated : 1 day, 6 hours ago IST
Bengaluru (Karnataka) [India], May 14 (ANI): Karnataka will soon have a manufacturing plant of Bharat Biotech's Covaxin in Maluru industrial area, near Kolara district, said Deputy Chief Minister and State COVID task force head Dr C N Ashwatha Narayana on Friday.
Bengaluru (Karnataka) [India], May 14 (ANI): Karnataka received a fresh stock of 75,000 doses of COVID vaccines on Friday, informed the state Health Minister Dr K Sudhakar.
Updated : 1 day, 16 hours ago IST
New Delhi [India], May 14 (ANI): Amid the worrying shortage of COVID-19 vaccines across the country, Delhi health minister Satyendar Jain on Friday said if there is a need to float a global tender, it should be done by the Central government.
Updated : 2 days, 10 hours ago IST
New Delhi [India], May 13 (ANI): Delhi Health Minister Satyendar Jain on Thursday said that he has suggested to the Union Health Ministry that the Central government should float a single global tender instead of various states to purchase COVID-19 vaccines.
Updated : 2 days, 12 hours ago IST
New Delhi [India], May 13 (ANI): Amid the reports of vaccine shortage from various state, Central government and Hyderabad based Bharat Biotech is willing to invite other companies who want to produce COVAXIN to increase the production, said NITI Aayog member, Dr VK Paul, on Thursday.
New Delhi [India], May 13 (ANI): Amid reports of the shortage of COVID-19 vaccine in various states, Sputnik vaccine has arrived in India, and "hopefully" it will be available in the market from next week, said Dr VK Paul, member (health) of the NITI Aayog, on Thursday.
Updated : 2 days, 14 hours ago IST
New Delhi [India], May 13 (ANI): Several vaccination centres where Covaxin is being administered in the national capital on Thursday remained closed for the age group of 18-44 years due to its non-availability.
Updated : 2 days, 17 hours ago IST
New Delhi [India], May 13 (ANI): The National Technical Advisory Group on Immunisation (NTAGI) on Thursday recommended an increase in the gap between two doses of Serum Institute of India's COVISHIELD to 12-16 weeks.
Updated : 2 days, 19 hours ago IST
New Delhi [India], May 13 (ANI): The Drugs Controller General of India (DCGI) on Thursday approved Phase 2 and 3 clinical trial of Bharat Biotech's COVAXIN vaccine in the age group of 2 to 18 years, informed the Ministry of Health and Family Welfare.
Updated : 3 days, 2 hours ago IST
New Delhi [India], May 13 (ANI): No centre in the national capital will be able to administer COVID-19 vaccine 'Covaxin' from Thursday to the age group of 18-44 years due to unavailability of its stock, said Aam Aadmi Party (AAP) MLA Atishi Marlena on Wednesday.
Updated : 3 days, 8 hours ago IST
New Delhi [India], May 12 (ANI): Delhi is left with 4,35,070 COVID vaccine doses in its balance stock out of which 16,900 doses are of Covaxin and 4,18,170 of Covishield reserved for the age group 18-44 years, informed the Delhi government.